Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting (Mar, 10.1007/s40258-022-00726-z, 2022)
APPLIED HEALTH ECONOMICS AND HEALTH POLICY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要